Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FD4ZD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,430
Award facts
- Contract value 100% obligated
- $45,429.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $45,429.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/ml auto-injector medication. This firm fixed-price delivery order, issued on September 29, 2025, with completion targeted for September 30, 2025, was awarded without a set-aside designation. The award represents a continuation of DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain, leveraging its capabilities to provide specialized pharmaceutical products to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a blanket agreement valued at $499,999,999 and valid through November 2026. This master contract enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support medical supply needs across military health facilities worldwide. The company's consistent success in securing federal pharmaceutical contracts demonstrates its established position as a preferred vendor for delivering specialized medications and injectable products to the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FD4ZD?
SPE2DB25FD4ZD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FD4ZD worth?
The government has obligated $45,430 on SPE2DB25FD4ZD.
Is contract SPE2DB25FD4ZD an order under another contract?
Yes. SPE2DB25FD4ZD is a delivery order under SPE2DB20D9214, an indefinite delivery contract.
Was contract SPE2DB25FD4ZD competed?
The extent of competition for SPE2DB25FD4ZD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award